Event: Poster presentation: Safety and Efficacy 31 Week Data of ANAVEX 2-73 in a Phase 2a
Study in Mild-Moderate Alzheimer’s Disease Patients
Date/Time: Wednesday, July 27, 2016
1:00 p.m. to 2:00 p.m. EDT
Location: Hall D/E, Metro Toronto Convention Centre, Toronto, ON